Up until now, the two most commonly used strategies to treat recurrent UTIs were long-term, low-dose antibiotic prophylaxis and post-coital antibiotic prophylaxis for women who have UTIs associated with sexual intercourse.
The reality is that antibiotics have their own set of complications. It is not uncommon for patients, particularly elderly patients, to develop severe allergic reactions or antibiotic-related diarrhea, both of which can be fatal in older adults. Furthermore, over-dependence on antibiotic strategies can lead to bacterial resistance.
Break the Vicious Cycle of Recurrent UTIs with Double-Action URIEXO®… An ounce of prevention is worth a pound of cure.
New non-prescription URIEXO® is a clinically proven, non-antibiotic option to UTI prevention. Only URIEXO® Double-Action is specially formulated with two clinically proven active ingredients (2000 mg of D-Mannose and 36 mg of PACs in its daily recommended dose) that have been demonstrated to be effective as prophylactic therapy for patients with recurrent urinary tract infections (UTIs).
URIEXO® provides your patients with a two-pronged and scientifically proven defence, against recurring UTIs. These two active ingredients, bind with UTI-causing bacteria in the urinary tract in two separate ways, preventing bacteria from adhering to the bladder wall and urinary tract, so that bacteria can safely be flushed out with urination. This double mode of action helps prevent the pain associated with urinary tract infections, and more importantly, protects your patient’s kidneys from potential damage of recurring UTIs.
We take a UNIQUE approach to UTI prevention.
URIEXO® SHIELDS your patients from recurring UTIs.
- Helps prevent Urinary Tract Infections and its symptoms:
- Painful or difficult urination
- Frequent urination
- Urgency to urinate
- Suprapubic/pelvic pain
- Two Medicinal Ingredients:
- D-Mannose (2000 mg/day)
- PACs, sourced from cranberry (36mg/day)
- Easy to Swallow Capsules
URIEXO®, a Natural Health Product to help prevent Urinary Tract Infections and its symptoms, has been reviewed and approved to be part of the new "Brand Recognition Program" recently introduced by the Society of Obstetricians and Gynaecologists of Canada (SOGC). The SOGC Brand Recognition Program aims to assist Canadian consumers to make informed choices when selecting over-the-counter products. This program is designed for non-prescription/over-the-counter products that are found to safely and effectively promote female sexual and reproductive health.
Eligible products are required to have:
- Received Health Canada licence for sale in the Canadian market;
- Demonstrated reasonable evidence of safety and efficacy, and pose no undue harm;
- Substantiated packaging claims and a perceived low risk.
Products are independently and carefully reviewed by a panel of medical professionals.